APAC Diagnostic Catheter Market

APAC Diagnostic Catheter Market Size (2024 to 2029)

The size of the Asia Pacific Diagnostic Catheter Market has been calculated at USD 603.68 Million in 2024. It is further estimated to be growing at a CAGR of 7.8% and worth USD 947.37 million by 2029.

Catheters are thin tubes made of medical grade material such as plastic, silicon rubber, polyvinyl chloride (PVC), and nylon.

Catheterization is a primary co-procedure performed with varied other medical procedures such as angioplasty, cardiac electrophysiology, and neurosurgery, wherein catheters are used. Various drivers of the market include the presence of a large patient population, increased patient awareness for minimally invasive surgeries, a rapid rise in prevalence of cardiovascular and kidney disorders, growth in per capita income, and increasing investments in the healthcare industry by key market players. 

However, inadequate quality assurance and price competition at domestic levels are expected to hamper this growth.

This research report on APAC Diagnostic Catheter Market has been segmented and sub-segmented into the following categories.

APAC Diagnostic Catheter Market Analysis By Type

• Imaging catheters
• Non-imaging catheters

APAC Diagnostic Catheter Market Analysis By Application

• Neurology
• Urology
• Gastroenterology
• Cardiology
• Others (Bronchoscopy and Gynecology)

APAC Diagnostic Catheter Market Analysis By End-user

• Hospitals
• Imaging & Diagnostic Centers

APAC Diagnostic Catheter Market Analysis By Country

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, Asia-Pacific is expected to witness the highest growth during the forecast period.

Notable companies dominating the Asia Pacific Diagnostic Catheter Market profiled in this report are Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic plc (Ireland), Johnson & Johnson (U.S.), Koninklijke Philips N.V. (Netherlands), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Cardinal Health, Inc. (U.S.), Edward Lifesciences Corporation (U.S.), and Terumo Corporation (Japan).